- Type
- services (award)
- Procedure
- Open
- Ref. number
- c9bcd77b-f07a-40d8-b2dd-5b736ba53a22
- CPV
- 73100000
The headline objectives of the present manufacturing project are the use of the deliverables in GLP compliant preclinical toxicology and safety pharmacology studies as well as a phase 1 first-in-human clinical trial. The…
objective of the project is to manufacture two alternative pharmaceutical dosage forms, sterile liquid and semi-solid, to enable dosing as i.v. infusion and topical administration, respectively. This solely relates to current lack of clinical target validation and the requirement to ready the techn
ology for proof-of-mechanism in systemic versus skin administration. We are targeting a virulence factor of S. aureus that may cause pulmonary or dermal infections.
HZI wishes to commission the following activities under Master Service Agr